DISC-0974 may have utility as monotherapy or in combination with other JAK inhibitors, according to Naseema Gangat, MBBS.
Naseema Gangat, MBBS
Advertisement
Articles by Naseema Gangat, MBBS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Gives Accelerated Approval to Sevabertinib in HER2+ NSCLC
2
Daraxonrasib Yields Activity in Previously Treated RAS-Mutant NSCLC
3
Why MRI Contrast Agents Are Not Interchangeable for Detecting Brain Metastases
4
INBRX-106 Plus Pembrolizumab Nearly Doubles Response Rate in HNSCC
5